Exact Sciences Development Company, LLC
Madison, WI, US· latest recorded location
Exact Sciences Development Company, LLC is named on 41 US grants and 57 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 41
- Published applications
- 57
- Inventors
- 46
- Granted in 2026 so far
- 0
- Most recent grant
- 15 Nov 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 9 | 8 |
| 2019 | 8 | 12 |
| 2020 | 9 | 14 |
| 2021 | 12 | 14 |
| 2022 | 3 | 7 |
| 2023 | 0 | 1 |
By publication year.
Technology areas
Share of 98 documents
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms95
- C12NMicroorganisms or enzymes15
- G01NInvestigating or analysing materials by determining their chemical or physical properties13
- A61PTherapeutic uses of medicines8
- C01BNon-metallic elements5
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the4
- C12YEnzymes3
- G16ZInformation and communication technology [ict] specially adapted for specific application fields, not3
- C07KPeptides2
- A61BMedical diagnosis and surgery1
Recent patents
- Real time cleavage assay15 Nov 2022US 11,499,179 B2
- Multiplexed KRAS mutation detection assay7 Jun 2022US 11,352,674 B2
- Using phage epitopes to profile the immune response19 Apr 2022US 11,307,203 B2
- Nucleic acid control molecules from non-human organisms28 Dec 2021US 11,208,680 B2
- Multiplex amplification detection assay II7 Dec 2021US 11,193,168 B2
- Detecting non-hodgkin lymphoma9 Nov 2023US 2023/0357852 A1
- Multiplexed Kras Mutation Detection Assay20 Oct 2022US 2022/0333210 A1
- Characterizing methylated dna, rna, and proteins in the detection of lung neoplasia5 May 2022US 2022/0136058 A1
- Multiplex Amplification Detection Assay II21 Apr 2022US 2022/0119862 A1
- Sampling device and analysis of methylated dna10 Mar 2022US 2022/0071605 A1
Most cited
By later US patents
- Compositions and methods for performing methylation detection assays32US 10,011,878 B22018
- Detection of lung neoplasia by analysis of methylated DNA20US 10,385,406 B22019
- Detecting esophageal disorders20US 10,435,755 B22019
- Multiplex amplification detection assay19US 10,704,081 B22020
- Detection of colon neoplasia by analysis of methylated DNA16US 11,118,228 B22021